Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis

The benefits and safety of intravenous recombinant tissue plasminogen activator (IV-tPA) for patients with mild ischaemic stroke (MIS) are still unclear. The objective of this meta-analysis was to evaluate the efficacy and safety of IV-tPA as treatment for patients with MIS. We performed a systemati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stroke Vasc Neurol
Autors principals: You, Shoujiang, Saxena, Anubhav, Wang, Xia, Tan, WeeYong, Han, Qiao, Cao, Yongjun, Liu, Chun-Feng
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2018
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5870640/
https://ncbi.nlm.nih.gov/pubmed/29600004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2017-000106
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars